Medical and Scientific: CSL boost as drug cleared of cancer links after scare

02 Apr 2021 - Medical and Scientific

CSL has a new ray of hope in its research pipeline, with an experimental haemophilia drug it acquired last year cleared of any links to cancer following a scare in its clinical trial. UniQure was in phase 3 trials for the product and had released strong data at the end of last year showing participants were responding positively. But just weeks later, the US Food and Drug Administration put a hold on the drug’s clinical trial after a participant was diagnosed with hepatocellular carcinoma, a type of liver cancer. However, UniQure this week released details of an investigation into the patient, concluding it was “highly unlikely” there was a link between the cancer and the company’s product.
Sydney Morning Herald; 02/04/2021; Page 26; The Age; 02/04/2021; Page 26